BREAKING: Fresenius Strikes $250M Deal To Settle Dialysis Drug MDL

Fresenius Medical Care has reached a $250 million agreement in principle to settle multidistrict litigation over the alleged side effects from its dialysis drugs GranuFlo and NaturaLyte, the company said Wednesday, a day after a bellwether trial was scheduled to begin in Massachusetts federal court.

If you or a loved one were on dialysis and subsequently were diagnosed with cardiopulmonary arrest or death, you may have a substantial claim and may be entitled to significant compensation. This is true if you were on dialysis in North Dakota or Minnesota or in a different state.

Solberg Stewart Miller represents plaintiffs who were on dialysis and were subsequently diagnosed with cardiopulmonary arrest or death.

Granuflo and Naturalyte are acid solutions that are used during dialysis. Granuflo and Naturalyte were made by Fresenius Medical Care, which is one of the leading manufactures for these types of products for the dialysis treatment. It is believed that over 100,000 people in the United States alone have been treated with Frensenius products during dialysis treatments. A Fresenius Medical Care internal memo was leaked to the FDA, leading the FDA to issue a Class I Recall.

According to the FDA website:
“FDA issued a Class I Recall notice for Fresenius Medical Care North America Naturalyte Liquid Acid Concentrate and Naturalyte GranuFlo (powder) Acid Concentrate. Inappropriate prescription of these products can lead to a high serum bicarbonate level in patients undergoing hemodialysis. This may contribute to metabolic alkalosis, which is a significant risk factor associated with low blood pressure, hypokalemia, hypoxemia, hypercapnia and cardiac arrhythmia, which, if not appropriately treated, may culminate in cardiopulmonary arrest. This product may cause serious adverse health consequences, including death.”
See: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm305630.htm

On March 29, 2012, the FDA issued a recall of GranuFlo and NaturaLyte, stating that the use of these products can result in dangerously high levels of bicarbonate, which can cause metabolic alkalosis – a condition associated with low blood pressure, cardiac arrhythmia, heart attack, cardiac arrest and other cardiovascular problems.

Solberg Stewart Miller represents plaintiffs on a contingent-fee basis, which means that if there is no recovery there will be no fees. Attorney consultations incur no obligation on your part and all initial consultations are free of charge. If Solberg Stewart Miller agrees to accept your case, the attorney fees are based on a percentage of your recovery.

There are strict time deadlines, called Statutes of Limitations, which must be met in all such cases. If you have a Granuflo or Naturalye case but do not file and serve your lawsuit before the time deadline you will be forever barred from bringing such a case. Fortunately, if you took Granuflo or Naturalyte in North Dakota or Minnesota the time deadlines are longer than in some other states. Nevertheless, there are still strict time deadlines in North Dakota and Minnesota, just like other states and if you miss the deadline you cannot pursue your claim. Therefore, if you believe that you or your loved one may have a Granuflo or Naturlyte claim because you were on dialysis, and suffered from cardiopulmonary arrest or death, you should immediately contact an attorney.